Access to essential medication is a primary right of every individual in all developed, developing and underdeveloped countries. This can be fulfilled by pharmaceutical supply chains (PSC) in place which will eliminate the boundaries between different organizations and will equip them to work collectively to make medicines reach even the remote corners of the globe. Due to multiple entities, which are geographically widespread, being involved and very complex goods and economic flows, PSC is very difficult to audit and resolve any issues involved. This has given rise to many issues, including increased threats of counterfeiting, inaccurate information propagation throughout the network because of data fragmentation, lack of customer confidence and delays in distribution of medication to the place in need. Hence, there is a strong need for robust PSC which is transparent to all parties involved and in which the whole journey of medicine from manufacturer to consumer can be tracked and traced easily. This will not only build safety for the consumers, but will also help manufacturers to build confidence among consumers and increase sales. In this article, a novel Distributed Ledger Technology (DLT) based transparent supply chain architecture is proposed and a proof-of-concept is implemented. Efficiency and scalability of the proposed architecture is evaluated and compared with existing solutions.
翻译:获得基本药品是所有发达国家、发展中国家和欠发达国家每个人的一项首要权利,可以通过建立消除不同组织之间界限的制药供应链来实现,使这些组织能够共同努力,使药品甚至能够到达全球偏远角落。由于多个实体,这些实体在地理上十分广泛,涉及众多,而且货物和经济流动非常复杂,因此很难审计和解决任何所涉问题。这引起了许多问题,包括由于数据分散、客户缺乏信心和药品向需要的地方分发延误而使假冒威胁增加、整个网络的信息传播不准确。因此,非常需要强有力的PSC,它对所有当事方透明,并且可以很容易地追踪和追踪从制造商到消费者的整个医药旅程。这不仅将建立消费者的安全,而且还将有助于制造商在消费者之间建立信任和增加销售量。在文章中,提出了基于透明供应链结构的新型分散技术(DLT),并落实了验证概念。对拟议结构的效率和可扩展性进行了评估,并与现有解决办法进行了比较。